Navigation Links
Skin tests confirms cancer

Scientists believe they have developed a screening technique for persons suffering from types of hereditary cancers.The Imperial Cancer Research Fund says investigations of skin lesions may allow doctors to identify people likely to suffer from a group of cancers, particularly those of the colon.

By looking at skin warts, benign growths and malignant skin tumours in members of families with a history of HNPCC //- hereditary non-polyposis colorectal cancer syndrome - it may be possible to identify people at high risk.

HNPCC has been linked to a defect in the repair mechanism for cells. Cells should replicate their DNA when they divide but if they do not they can cause alterations to microsatellites - the short repetitive sequences of genetic code contained in DNA. This phenomenon, known as microsatellite instability (MSI), can cause tumours to develop.

Dr Bataille and her team inspected skin lesions of families with and without a history of hereditary colon cancer. In those with no family history, MSI was not found to be present. "Detecting MSI in the skin could potentially be used in clinical practice to screen individuals in families at risk," said Dr Bataille.

There are about 2,700 HNPCC sufferers in the Asis and of those, about 34% are also susceptible to other types of tumours, particularly those of the womb and the ovary.


'"/>




Page: 1

Related medicine news :

1. IMA wants members not to do sex determination tests during pregnancy
2. Doctors advice early anemia tests
3. Genetic tests for cancer
4. Space research leads to needle-free blood tests
5. Early diagnosis for autism from blood tests may be possible
6. Genetically modified rice faces strong protests in Asia
7. Child specific HIV drugs and laboratory tests should be developed
8. Condom Vending Machines Provoke Protests
9. Huge demand for high street chlamydia tests
10. FDA approves Phase 0 trial which tests experimental drugs on humans
11. Initial tests negative for bird flu in Romanian Woman
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: